Article Details

Samsung Biologics and TG Therapeutics expand blood cancer partnership

Retrieved on: 2021-04-27 13:06:32

Tags for this article:

Click the tags to see associated articles and topics

Samsung Biologics and TG Therapeutics expand blood cancer partnership. View article details on hiswai:

Excerpt

“Targeting CD20 using monoclonal antibodies has proven to be an important therapeutic approach for the management of B-cell malignancies and ...

Article found on: www.biopharma-reporter.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up